SCHEMBL5672045

SCHEMBL5672045

NC(=O)N1CC(=O)[CH]CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2687153 0.72 LMNA (0.31)
SCHEMBL11666000 0.70 HSD17B3 (0.53)
SCHEMBL6538147 0.68
SCHEMBL15252356 0.65 CRBN (0.37)
Squamolone SCHEMBL1051735 0.64
Squamolone SCHEMBL28367081 0.63 LMNA (0.57)
SCHEMBL4697679 0.63
SCHEMBL4702017 0.63 LMNA (0.52)
SCHEMBL5240878 0.61
SCHEMBL1424272 0.61 LMNA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1511745-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2006-11-15 EP disclosed
EP-1511745-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2006-11-15 EP disclosed
US-20050256100-A1 Protease inhibitors JEONG JAE U 2005-11-17 US disclosed
US-20050256100-A1 Protease inhibitors JEONG JAE U 2005-11-17 US disclosed
EP-1511745-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2005-03-09 EP disclosed
EP-1511745-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2005-03-09 EP disclosed
WO-2003097593-A3 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-07-08 WO disclosed
WO-2003097593-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-11-27 WO disclosed
WO-2003097593-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-11-27 WO disclosed